ClinicalTrials.Veeva

Menu

Evaluation of Response to Pain From Skull Pin Fixation in Craniotomies

D

Diskapi Teaching and Research Hospital

Status

Not yet enrolling

Conditions

Electroencephalography
Craniotomy Surgery
Pain Management

Treatments

Procedure: Local Anesthetic Injection
Drug: Opioid Anesthetics
Procedure: Scalp nerve block

Study type

Observational

Funder types

Other

Identifiers

NCT06811701
AESH-BADEK-2016-1016

Details and patient eligibility

About

The goal of this observational study is to investigate the relationship between the response to skull pin fixation pain and the analysis of blood pressure, heart rate, and brain wave activity in adults undergoing brain surgery. The main questions it aims to answer are:

Does the analysis of blood pressure, heart rate, and brain wave activity indicate the patient's response to skull pin fixation pain during brain surgery? How do the methods used to reduce skull pin fixation pain in brain surgeries affect narcotic opioid consumption? The researchers will monitor the patients' response to skull pin fixation pain during surgery through the analysis of brain wave activity.

Full description

Patients with an ASA (American Society of Anesthesiologists) score of I-II who are undergoing elective craniotomy under general anesthesia with the use of a skull clamp will be included in the study. The methods used to manage patients' pin-related pain will be recorded on the follow-up form: 1-intravenous opioids, 2- local anesthetic (LA) injection at the pin site, and 3- scalp block. The patients' hemodynamic responses and their reactions to painful stimuli, as recorded by the BIS-DSA monitor, will be documented during the placement of the skull clamp. These records are automatically archived in the BIS-DSA device. Waveform analyses from the BIS-DSA will later be converted into numerical values using the "Hue formula."

Enrollment

120 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adult patients aged 18-70 years undergoing elective craniotomy.
  • Patients classified as ASA I-II according to the American Society of Anesthesiologists (ASA) classification.
  • Patients scheduled for surgery under general anesthesia.
  • Patients who provide written informed consent to participate in the study.
  • Patients with normal cognitive function (i.e., no diagnosed dementia or severe cognitive impairment).
  • Patients with a preoperative BIS value within the normal range (i.e., no extreme baseline deviations).

Exclusion criteria

  • Patients classified as ASA III or higher.
  • Patients with neurological disorders (e.g., Parkinson's disease, epilepsy, stroke history).
  • Patients with psychiatric disorders (e.g., severe depression, schizophrenia) that may affect pain perception and response.
  • Patients with known allergies to local anesthetics or opioids.
  • Pregnant or breastfeeding women.
  • Patients with contraindications to anesthesia, including but not limited to:
  • Severe cardiovascular disease (e.g., uncontrolled hypertension, recent myocardial infarction).
  • Severe respiratory disease (e.g., COPD, uncontrolled asthma).
  • Patients with any neurological or pharmacological condition that may interfere with BIS-DSA or EEG measurements.
  • Patients with preoperative chronic opioid use (≥3 months) due to potential tolerance affecting response to intraoperative analgesia.
  • Patients with a history of substance abuse that may alter the BIS response or anesthetic metabolism.
  • Patients with significant hearing or communication impairments, preventing them from understanding or responding to preoperative assessments.
  • Patients with significant scalp pathology (e.g., infections, scars, large vascular malformations) at the BIS electrode placement site, which may interfere with signal acquisition.

Trial design

120 participants in 3 patient groups

Group 1: Scalp group
Description:
"This group consists of patients who receive a scalp nerve block for pain management during skull pin fixation."
Treatment:
Procedure: Scalp nerve block
Group 2: Opioid Group
Description:
"This group consists of patients who receive intravenous opioids for pain management during skull pin fixation."
Treatment:
Drug: Opioid Anesthetics
Group 3: Local Anesthetic Group
Description:
"This group consists of patients who receive a local anesthetic injection at the pin site before skull pin fixation."
Treatment:
Procedure: Local Anesthetic Injection

Trial contacts and locations

0

Loading...

Central trial contact

Ceyda Ozhan Caparlar, MD; Aylin Kılıcarslan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems